Last Price$7.00.0%
Market Cap$9,645.8M
LTM Net Debt
$812.5M
YoY Growth
+162.1%
3Y CAGR
-25.8%
5Y CAGR
+6.4%
Stock quality & Intrinsic value
5/10
54.0% overvalued
Natura &Co Holding S.A. Net Debt
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt | ($135.9M) | $670.0M | $858.6M | $244.3M | $641.6M | $1,701.9M | $1,642.8M | $1,929.5M | $1,794.0M | $1,840.9M | $2,047.3M | ($105.5M) |
Overvalued or undervalued?
Check the intrinsic value for NTCO
and see if it's the right time to invest.
Natura &Co Holding S.A. (NTCO) Net Debt comparison analysis
General
LTM Net Debt
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Natura &Co Holding S.A.NTCO
$812.5M
162.1%
(25.7%)
12.3%
Median Peer Set
$6,609.5M
(5.8%)
0.2%
(0.2%)
Unilever PLCUL
$25.4B
3.6%
3.3%
20.6%
The Procter & Gamble CompanyPG
$24.5B
(5.3%)
0.5%
1.7%
Kenvue Inc.KVUE
$7,649.0M
8.6%
N/A
N/A
Colgate-Palmolive CompanyCL
$7,416.0M
(6.4%)
1.9%
(0.5%)
The Estée Lauder Companies Inc.EL
$6,797.0M
2.5%
21.9%
7.9%
Kimberly-Clark CorporationKMB
$6,422.0M
(8.5%)
(8.7%)
(2.9%)
The Clorox CompanyCLX
$2,802.0M
(11.8%)
(6.2%)
(1.2%)
Church & Dwight Co., Inc.CHD
$1,240.5M
(45.1%)
(20.5%)
(9.6%)
Coty Inc.COTY
$80.5M
(97.8%)
(74.4%)
(59.9%)
Hims & Hers Health, Inc.HIMS
($288.9M)
37.7%
6.1%
37.5%
NTCO key stats
USD
BRL
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 3,256.1 0.0% | 3,257.7 0.1% | 3,151.9 (3.2%) | 2,405.6 (23.7%) | 2,278.7 (5.3%) | 3,082.1 35.3% | 3,683.8 19.5% | 3,661.4 (0.6%) | 7,221.0 97.2% | 7,438.1 3.0% | 7,036.5 (5.4%) | 5,344.0 (24.1%) |
| Cost of Goods Sold (COGS) | 958.5 | 981.0 | 957.3 | 784.6 | 757.5 | 910.6 | 1,040.1 | 1,022.4 | 2,587.4 | 2,594.8 | 2,546.5 | 1,933.8 |
% margin | 2,297.5 70.6% | 2,276.7 69.9% | 2,194.6 69.6% | 1,621.1 67.4% | 1,521.2 66.8% | 2,171.5 70.5% | 2,643.7 71.8% | 2,639.0 72.1% | 4,633.6 64.2% | 4,843.3 65.1% | 4,489.9 63.8% | 3,410.2 63.8% |
| Operating Expenses | 1,610.6 | 1,679.1 | 1,710.3 | 1,258.4 | 1,229.0 | 1,642.5 | 2,206.0 | 2,295.8 | 4,336.9 | 4,385.8 | 4,500.0 | 3,441.1 |
| Research & Development Expenses (R&D) | 81.5 | 85.1 | 92.8 | 63.6 | 22.1 | 25.0 | 28.2 | 22.7 | 52.9 | 41.4 | 52.9 | 32.3 |
| Selling, General & Administrative Expenses (SG&A) | 1,588.2 | 1,620.8 | 1,622.4 | 1,258.4 | 1,225.0 | 1,720.8 | 2,140.7 | 2,230.9 | 4,235.9 | 4,185.9 | 4,349.0 | 2,883.9 |
% margin | 702.0 21.6% | 653.7 20.1% | 578.7 18.4% | 362.7 15.1% | 292.2 12.8% | 425.0 13.8% | 345.5 9.4% | 838.7 22.9% | 691.7 9.6% | 428.6 5.8% | (5.5) (0.1%) | (30.9) (0.6%) |
| Interest Income | 20.8 | 13.1 | 17.9 | 15.2 | 18.3 | 51.4 | 35.6 | 495.8 | 926.7 | 49.0 | 104.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 121.3 | 173.6 | 708.7 | 1,129.2 | 158.6 | 144.1 | 300.2 |
| Pre-tax Income | 666.2 | 584.5 | 466.5 | 266.6 | 122.9 | 303.8 | 185.2 | 77.2 | (48.1) | 16.9 | (456.6) | (533.3) |
% effective tax rate | 217.5 32.7% | 190.5 32.6% | 151.1 32.4% | 107.4 40.3% | 34.2 27.8% | 94.1 31.0% | 34.4 18.6% | 37.8 48.9% | 53.7 (111.8%) | (194.1) (1,148.4%) | 23.2 (5.1%) | (17.3) 3.2% |
% margin | 448.7 13.8% | 391.6 12.0% | 311.8 9.9% | 156.4 6.5% | 85.4 3.7% | 209.7 6.8% | 150.8 4.1% | 39.4 1.1% | (101.8) (1.4%) | 194.1 2.6% | (479.7) (6.8%) | (664.1) (12.4%) |
| EPS | 21.25 | 18.67 | 14.83 | 7.49 | 4.01 | 9.88 | 7.22 | 1.87 | (3.37) | 5.77 | (14.37) | 17.70 |
| Diluted EPS | 21.25 | 18.67 | 14.83 | 7.49 | 4.01 | 9.88 | 7.10 | 1.87 | (3.37) | 5.69 | (14.37) | 17.62 |
% margin | 873.4 26.8% | 720.0 22.1% | 652.2 20.7% | 471.2 19.6% | 301.9 13.2% | 569.6 18.5% | 535.7 14.5% | 544.5 14.9% | 819.1 11.3% | 765.8 10.3% | 113.7 1.6% | 84.2 1.6% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Natura &Co Holding S.A.'s Net Debt?
As of today, Natura &Co Holding S.A.'s last 12-month Net Debt is $812.5M, based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Natura &Co Holding S.A.'s Net Debt growth rate?
Over the last year, Natura &Co Holding S.A.'s Net Debt growth was 162.1%. The average annual Net Debt growth rates for Natura &Co Holding S.A. have been (26.1%) over the past three years, 6.4% over the past five years.
3) Is Natura &Co Holding S.A.'s Net Debt growth rate Good?
Over the last year, Natura &Co Holding S.A.'s Net Debt growth was 162.1%, which is higher than industry growth of (0.4%). It indicates that Natura &Co Holding S.A.'s Net Debt growth is Bad.